A novel HVEM-Fc recombinant protein for lung cancer immunotherapy
Abstract Background The ubiquitously expressed transmembrane protein, Herpesvirus Entry Mediator (HVEM), functions as a molecular switch, capable of both activating and inhibiting the immune response depending on its interacting ligands. HVEM-Fc is a novel recombinant fusion protein with the potenti...
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
BMC
2025-02-01
|
| シリーズ: | Journal of Experimental & Clinical Cancer Research |
| オンライン･アクセス: | https://doi.org/10.1186/s13046-025-03324-8 |